Pearl River Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,920
| Closed | -$220K | – | 405 |
|
|
2024
Q1 | $220K | Sell |
11,920
-21,245
| -64% | -$393K | 0.03% | 429 |
|
|
2023
Q4 | $1.04M | Buy |
33,165
+1,536
| +5% | +$48.1K | 0.17% | 192 |
|
|
2023
Q3 | $659K | Buy |
31,629
+2,773
| +10% | +$57.8K | 0.1% | 283 |
|
|
2023
Q2 | $691K | Sell |
28,856
-2,760
| -9% | -$66.1K | 0.11% | 270 |
|
|
2023
Q1 | $595K | Buy |
31,616
+14,324
| +83% | +$270K | 0.09% | 288 |
|
|
2022
Q4 | $275K | Sell |
17,292
-12,826
| -43% | -$204K | 0.05% | 424 |
|
|
2022
Q3 | $493K | Buy |
30,118
+16,131
| +115% | +$264K | 0.09% | 290 |
|
|
2022
Q2 | $197K | Sell |
13,987
-9,461
| -40% | -$133K | 0.05% | 411 |
|
|
2022
Q1 | $568K | Buy |
23,448
+14,059
| +150% | +$341K | 0.16% | 206 |
|
|
2021
Q4 | $219K | Buy |
+9,389
| New | +$219K | 0.06% | 363 |
|
|
2021
Q1 | – | Sell |
-7,153
| Closed | -$382K | – | 377 |
|
|
2020
Q4 | $382K | Sell |
7,153
-8,463
| -54% | -$452K | 0.14% | 233 |
|
|
2020
Q3 | $644K | Buy |
15,616
+11,171
| +251% | +$461K | 0.27% | 126 |
|
|
2020
Q2 | $215K | Buy |
+4,445
| New | +$215K | 0.11% | 244 |
|
|
2019
Q1 | – | Sell |
-718
| Closed | -$12K | – | 344 |
|
|
2018
Q4 | $12K | Buy |
+718
| New | +$12K | 0.06% | 468 |
|